sulfanilamide has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zajda, A | 1 |
| Sikora, J | 1 |
| Hynninen, M | 1 |
| Tampio, J | 1 |
| Huttunen, KM | 1 |
| Markowicz-Piasecka, M | 1 |
1 other study available for sulfanilamide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Substituent effects of sulfonamide derivatives of metformin that can dually improve cellular glucose utilization and anti-coagulation.
Topics: Benzenesulfonamides; Diabetes Mellitus, Type 2; Endothelial Cells; Glucose; Humans; Hypoglycemic Age | 2023 |